Big Pharma Earnings Watch: Johnson & Johnson

Price Hikes Fuel Better Than Expected Earnings For Brand Name Giant

As millions of Americans struggle to afford their medications amid unprecedented health care and economic challenges, the first earnings report from a Big Pharma giant demonstrates that hiking prices on American patients continues to be a profitable practice for the industry.

Today, brand name drug company Johnson & Johnson reported better than expected Q1 earnings after hiking prices earlier this year.

Johnson & Johnson

Check back next week as we continue to monitor Q1 earnings announcements from brand name drug companies.

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.